• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人胃蛋白酶及其与胃蛋白酶抑制剂复合物的晶体结构。

Crystal structure of human pepsin and its complex with pepstatin.

作者信息

Fujinaga M, Chernaia M M, Tarasova N I, Mosimann S C, James M N

机构信息

Department of Biochemistry, University of Alberta, Edmonton, Canada.

出版信息

Protein Sci. 1995 May;4(5):960-72. doi: 10.1002/pro.5560040516.

DOI:10.1002/pro.5560040516
PMID:7663352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2143119/
Abstract

The three-dimensional crystal structure of human pepsin and that of its complex with pepstatin have been solved by X-ray crystallographic methods. The native pepsin structure has been refined with data collected to 2.2 A resolution to an R-factor of 19.7%. The pepsin:pepstatin structure has been refined with data to 2.0 A resolution to an R-factor of 18.5%. The hydrogen bonding interactions and the conformation adopted by pepstatin are very similar to those found in complexes of pepstatin with other aspartic proteinases. The enzyme undergoes a conformational change upon inhibitor binding to enclose the inhibitor more tightly. The analysis of the binding sites indicates that they form an extended tube without distinct binding pockets. By comparing the residues on the binding surface with those of the other human aspartic proteinases, it has been possible to rationalize some of the experimental data concerning the different specificities. At the S1 site, valine at position 120 in renin instead of isoleucine, as in the other enzymes, allows for binding of larger hydrophobic residues. The possibility of multiple conformations for the P2 residue makes the analysis of the S2 site difficult. However, it is possible to see that the specific interactions that renin makes with histidine at P2 would not be possible in the case of the other enzymes. At the S3 site, the smaller volume that is accessible in pepsin compared to the other enzymes is consistent with its preference for smaller residues at the P3 position.

摘要

人胃蛋白酶及其与胃蛋白酶抑制剂复合物的三维晶体结构已通过X射线晶体学方法解析。天然胃蛋白酶结构已根据收集到的分辨率为2.2埃的数据进行精修,R因子为19.7%。胃蛋白酶-胃蛋白酶抑制剂结构已根据分辨率为2.0埃的数据进行精修,R因子为18.5%。胃蛋白酶抑制剂的氢键相互作用和构象与在胃蛋白酶抑制剂与其他天冬氨酸蛋白酶复合物中发现的非常相似。酶在与抑制剂结合时会发生构象变化,从而更紧密地包裹抑制剂。结合位点分析表明,它们形成一个没有明显结合口袋的延伸管。通过将结合表面上的残基与其他人天冬氨酸蛋白酶的残基进行比较,已能够合理解释一些关于不同特异性的实验数据。在S1位点,肾素中第120位的缬氨酸而非其他酶中的异亮氨酸,使得更大的疏水残基能够结合。P2残基存在多种构象的可能性使得对S2位点的分析变得困难。然而,可以看出,肾素与P2位组氨酸的特异性相互作用在其他酶的情况下是不可能的。在S3位点,与其他酶相比,胃蛋白酶中可利用的体积较小,这与其对P3位置较小残基的偏好一致。

相似文献

1
Crystal structure of human pepsin and its complex with pepstatin.人胃蛋白酶及其与胃蛋白酶抑制剂复合物的晶体结构。
Protein Sci. 1995 May;4(5):960-72. doi: 10.1002/pro.5560040516.
2
Statistical coupling analysis of aspartic proteinases based on crystal structures of the Trichoderma reesei enzyme and its complex with pepstatin A.基于里氏木霉天冬氨酸蛋白酶及其与胃蛋白酶抑制剂A复合物晶体结构的统计偶联分析
J Mol Biol. 2008 Oct 10;382(3):763-78. doi: 10.1016/j.jmb.2008.07.043. Epub 2008 Jul 22.
3
X-ray analyses of aspartic proteinases. V. Structure and refinement at 2.0 A resolution of the aspartic proteinase from Mucor pusillus.天冬氨酸蛋白酶的X射线分析。V. 微小毛霉天冬氨酸蛋白酶在2.0埃分辨率下的结构与精修
J Mol Biol. 1993 Mar 5;230(1):260-83.
4
Crystal structures of Aspergillus oryzae aspartic proteinase and its complex with an inhibitor pepstatin at 1.9A resolution.米曲霉天冬氨酸蛋白酶及其与抑制剂胃蛋白酶抑制剂复合物的晶体结构,分辨率为1.9埃。
J Mol Biol. 2003 Mar 7;326(5):1503-11. doi: 10.1016/s0022-2836(03)00078-0.
5
Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.与抑制剂胃蛋白酶抑制剂复合的乳白耙齿菌天冬氨酸蛋白酶的晶体结构
J Mol Biol. 2004 Aug 27;341(5):1227-35. doi: 10.1016/j.jmb.2004.06.049.
6
Comparative modelling and analysis of amino acid substitutions suggests that the family of pregnancy-associated glycoproteins includes both active and inactive aspartic proteinases.氨基酸取代的比较建模与分析表明,妊娠相关糖蛋白家族既包括活性天冬氨酸蛋白酶,也包括非活性天冬氨酸蛋白酶。
Protein Eng. 1996 Oct;9(10):849-56. doi: 10.1093/protein/9.10.849.
7
Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3.蛔虫胃蛋白酶抑制剂-3抑制猪胃蛋白酶的结构基础
Nat Struct Biol. 2000 Aug;7(8):653-7. doi: 10.1038/77950.
8
Structure of the Rhizomucor miehei aspartic proteinase complexed with the inhibitor pepstatin A at 2.7 A resolution.米黑根毛霉天冬氨酸蛋白酶与抑胃酶肽A复合物在2.7埃分辨率下的结构。
Acta Crystallogr D Biol Crystallogr. 1999 Mar;55(Pt 3):625-30. doi: 10.1107/s0907444998013961.
9
X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.胃蛋白酶抑制剂A与含他汀的人肾素抑制剂和内皮蛋白酶复合物的X射线晶体学研究
Biochem J. 1993 Jan 15;289 ( Pt 2)(Pt 2):363-71. doi: 10.1042/bj2890363.
10
Molecular model for the binary complex of uropepsin and pepstatin.胃蛋白酶原与胃蛋白酶抑制剂二元复合物的分子模型。
Biochem Biophys Res Commun. 2001 Sep 14;287(1):277-81. doi: 10.1006/bbrc.2001.5555.

引用本文的文献

1
Structural determinants for pH-dependent activation of a plant metacaspase.植物metacaspase pH依赖性激活的结构决定因素
Nat Commun. 2025 May 29;16(1):4973. doi: 10.1038/s41467-025-60253-y.
2
Familial Alzheimer mutations stabilize synaptotoxic γ-secretase-substrate complexes.家族性阿尔茨海默病突变稳定促突触毒性 γ-分泌酶底物复合物。
Cell Rep. 2024 Feb 27;43(2):113761. doi: 10.1016/j.celrep.2024.113761. Epub 2024 Feb 13.
3
Non-Canonical Amino Acids in Analyses of Protease Structure and Function.非天然氨基酸在蛋白酶结构与功能分析中的应用。
Int J Mol Sci. 2023 Sep 13;24(18):14035. doi: 10.3390/ijms241814035.
4
AlphaFold-Multimer predicts cross-kingdom interactions at the plant-pathogen interface.AlphaFold-Multimer 预测了植物-病原体界面的跨物种相互作用。
Nat Commun. 2023 Sep 27;14(1):6040. doi: 10.1038/s41467-023-41721-9.
5
Phylogenetic and AlphaFold predicted structure analyses provide insights for A1 aspartic protease family classification in .系统发育分析和AlphaFold预测结构分析为A1天冬氨酸蛋白酶家族在……中的分类提供了见解。
Front Plant Sci. 2023 Feb 3;14:1072168. doi: 10.3389/fpls.2023.1072168. eCollection 2023.
6
Molecular and in vivo studies of a glutamate-class prolyl-endopeptidase for coeliac disease therapy.用于治疗乳糜泻的谷氨酸类脯氨酰内肽酶的分子和体内研究。
Nat Commun. 2022 Aug 1;13(1):4446. doi: 10.1038/s41467-022-32215-1.
7
Papain-cetylpyridinium chloride and pepsin-cetylpyridinium chloride; two novel, highly sensitive, concentration, digestion and decontamination techniques for culturing mycobacteria from clinically suspected pulmonary tuberculosis cases.木瓜蛋白酶-十六烷基氯化吡啶和胃蛋白酶-十六烷基氯化吡啶;两种新型、高敏感、浓缩、消化和去污技术,用于从临床疑似肺结核病例中培养分枝杆菌。
PLoS One. 2020 Aug 4;15(8):e0236700. doi: 10.1371/journal.pone.0236700. eCollection 2020.
8
An →* Interaction in the Bound Substrate of Aspartic Proteases Replicates the Oxyanion Hole.天冬氨酸蛋白酶结合底物中的一种相互作用复制了氧负离子洞。
ACS Catal. 2019 Feb 1;9(2):1464-1471. doi: 10.1021/acscatal.8b04142. Epub 2018 Nov 29.
9
Gastric cancer and Hedgehog signaling pathway: emerging new paradigms.胃癌与刺猬信号通路:新出现的范例
Genes Cancer. 2018 Jan;9(1-2):1-10. doi: 10.18632/genesandcancer.168.
10
Position-dependent impact of hexafluoroleucine and trifluoroisoleucine on protease digestion.六氟亮氨酸和三氟异亮氨酸对蛋白酶消化的位置依赖性影响
Beilstein J Org Chem. 2017 Dec 22;13:2869-2882. doi: 10.3762/bjoc.13.279. eCollection 2017.

本文引用的文献

1
Detection, delineation, measurement and display of cavities in macromolecular structures.大分子结构中空洞的检测、描绘、测量及显示。
Acta Crystallogr D Biol Crystallogr. 1994 Mar 1;50(Pt 2):178-85. doi: 10.1107/S0907444993011333.
2
Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling.通过动力学和基于规则的分子建模探索人组织蛋白酶D的亚位点结合特异性。
Protein Sci. 1993 Feb;2(2):264-76. doi: 10.1002/pro.5560020215.
3
X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.胃蛋白酶抑制剂A与含他汀的人肾素抑制剂和内皮蛋白酶复合物的X射线晶体学研究
Biochem J. 1993 Jan 15;289 ( Pt 2)(Pt 2):363-71. doi: 10.1042/bj2890363.
4
Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.人组织蛋白酶D天然形式和抑制形式的晶体结构:对溶酶体靶向和药物设计的启示
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6796-800. doi: 10.1073/pnas.90.14.6796.
5
The clinical potential of renin inhibitors and angiotensin antagonists.肾素抑制剂和血管紧张素拮抗剂的临床潜力。
Drugs. 1994 Apr;47(4):586-98. doi: 10.2165/00003495-199447040-00003.
6
Gastric proteinases--structure, function, evolution and mechanism of action.胃蛋白酶——结构、功能、进化及作用机制
Essays Biochem. 1981;17:52-84.
7
Three-dimensional structure of the complex of the Rhizopus chinensis carboxyl proteinase and pepstatin at 2.5-A resolution.华根霉羧基蛋白酶与胃蛋白酶抑制剂复合物在2.5埃分辨率下的三维结构。
Biochemistry. 1982 Dec 21;21(26):6956-62. doi: 10.1021/bi00269a052.
8
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.蛋白质二级结构词典:氢键和几何特征的模式识别
Biopolymers. 1983 Dec;22(12):2577-637. doi: 10.1002/bip.360221211.
9
Structure and refinement of penicillopepsin at 1.8 A resolution.青霉胃蛋白酶在1.8埃分辨率下的结构与精修
J Mol Biol. 1983 Jan 15;163(2):299-361. doi: 10.1016/0022-2836(83)90008-6.
10
Cloning and sequence analysis of cDNA for human renin precursor.人肾素前体cDNA的克隆与序列分析
Proc Natl Acad Sci U S A. 1983 Dec;80(24):7405-9. doi: 10.1073/pnas.80.24.7405.